drugset / Trial / NCT01817894

Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

NCT01817894

Phase 4 Completed 22 enrolled Bispebjerg Hospital
NaSingle-groupSingle-blindTreatment

Summary

Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal.

Timeline

Start
2012-01
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Eflornithine Small molecule 11.5 %

Indications